Stable Angina

Transcript

Welcome to the CPPE ischaemic heart disease page. Ischaemic heart disease or IHD is a major cause of death. Around 2 million people in the UK suffer from angina which is the most common symptom. Pharmacy professionals can make many interventions both to prevent the development of IHD and support patients to reduce their risks of further progression through medicines optimisation. Here you will find learning resources for pharmacy professionals in all sectors of practice. Patients often take multiple medicines and the resources on this page will support you in optimising medicines and supporting patients to get the best from them. Additional resources link to national guidance which will support evidence-based decision making around medicines. There are additional tools to apply to practice to support reduction of cardiovascular risk. As this is quite a broad topic the ‘test yourself’ area of the page may be a good place to start to help you identify your personal learning needs.

The aim of this e-course is to develop your knowledge and skills in cardiovascular therapeutics. This will enable you to provide a person-centred approach to support the healthcare of people living with or at higher risk of cardiovascular disease. It is designed for pharmacy professionals working in all areas of practice.

To facilitate your learning, we have structured the course into seven units. Some units are larger than others, but we estimate that you will need to commit an average of three hours of learning for each unit.

• Unit 1 – Introduction to cardiovascular therapeutics
• Unit 2 – Atrial fibrillation
• Unit 3 – Blood pressure
• Unit 4 – Cholesterol
• Unit 5 – Stable angina
• Unit 6 – Acute coronary syndrome
• Unit 7 – Heart failure

Learning Outcomes:

On completion of all aspects of this learning programme, you should be able to:

• describe the anatomy and function of the cardiovascular system
• explain the changes to cardiovascular system anatomy and function occurring in common cardiovascular conditions
• identify opportunities to develop your role and professional networks to deliver holistic and seamless care for people living with or at higher risk of cardiovascular disease
• apply your knowledge of medicines and cardiovascular guidelines to support evidence-based decisions and medicines optimisation for the prevention and treatment of cardiovascular disease
• demonstrate a shared decision making approach to the care of people living with or at higher risk of cardiovascular disease
• create a personal action plan that describes the actions you will take to support people living with or at higher risk of cardiovascular disease

This factsheet covers coronary heart disease in general while offering a description of what acute coronary syndromes are. It goes on to discuss management options and signpost to patient resources.

The aim of this e-learning programme is to provide you with a better understanding of vascular risk and the NHS health check programme.

It looks at the health policy surrounding the NHS health check programme and how it is commissioned. This learning defines cardiovascular risk and looks at some of the different assessment tools available and how these are used to estimate an individual’s cardiovascular risk.

It looks at the importance of communication with patients about their modifiable risk factors. Information on how to perform the NHS health check has been included and how to embed clinical governance into your NHS health check service.

Learning Outcomes:

• define the term cardiovascular risk and discuss which vascular diseases are included in the NHS health check programme
• describe how the NHS health check programme fits into current health policy, how it is commissioned and some of the practical aspects of providing a pharmacy-based service
• assess an individual’s risk of developing cardiovascular disease (CVD) using appropriate evidence-based tools
• explain management options for modifiable risk factors following an NHS health check
• manage patients identified as having low, medium or high risk
• identify situations where referral to another practitioner is appropriate following the NHS health check
• develop strategies for communicating with patients who are at risk of CVD.

The focus of this learning programme is to consider options for second-line angina treatment and how primary care teams can contribute to delivering a positive patient experience for people with angina.

Learning Outcomes:

• discuss the evidence base underpinning second-line medicines for stable angina
• assess which second-line medicine is most appropriate for an individual
• outline the key points for medicines optimisation in stable angina
• be aware of resources, including those for patients, to support medicines optimisation in this clinical area
• develop an action plan to improve medicines optimisation and reduce hospital admissions.

This e-learning programme provides an overview of the management of stable angina. It will equip learners with the knowledge and skills to offer a comprehensive medicines management service to people with this condition.

Please note: this e-learning programme has been developed and provided by the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD). Users should recognise that this programme will refer to Northern Ireland's policies and organisations. After ordering this programme, you will be redirected to their website where the resource is hosted. Please be aware that CPPE does not maintain control over the accuracy and currency of this programme.

Learning Outcomes:

• describe the factors involved in the diagnosis of stable angina
• identify the risk factors associated with increased mortality in patients with stable angina
• adopt an evidence-based approach to the management of stable angina
• make recommendations for second-line treatment if first-line therapy is unsuitable or cannot be tolerated
• understand the role of novel medication for patients with stable angina.

This e-assessment is linked with the CPPE Fundamentals of cardiovascular therapeutics e-course programme, and assesses you on the learning outcomes in that programme. 

Why should I do this assessment?

This e-assessment completes the learning you began with the CPPE Fundamentals of cardiovascular therapeutics e-course. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a CPD entry on the learning. It may also provide evidence for achieving competencies in the RPS Foundation or Advanced Pharmacy Frameworks. If you are working towards completing a Declaration of Competence for a pharmacy service, successful completion of this assessment will provide evidence of your learning.

This e-assessment is linked with the CPPE Vascular risk and the NHS health check programme and assesses you on the learning outcomes within that programme.

Why should I do this assessment?

This reflective essay is linked with the CPPE Stable anginadistance learning programme and assesses you on the learning objectives within that programme.

Please note: this assessment is only available to GPhC registrants in England.

Why should I do this assessment?

Use this tool to calculate a person’s risk of developing a heart attack or stroke over the next ten years.

NICE CG126 Stable angina: management

Coronary heart disease is a very common condition affecting around 2.3 million people in the UK. CHD is sometimes called ischaemic heart disease (IHD) or coronary artery disease (CAD). Some people may also refer to it as heart disease.

Angina is a symptom. It’s a pain or an uncomfortable feeling when blood flow to your heart is reduced. It's not dangerous but it can be a sign of heart problem, like coronary heart disease.

It's usually felt in your chest. Some people feel the pain in their arm, neck, stomach, back or jaw.